Chapter 437: Stage Results

readx;

"Wenxiu, Mom did it wrong before. Pen × fun × Pavilion www. biquge。 info If it can be redeemed, even if I let my mother go to Tanshan to beg that Qin Chuan, it will be fine. But now that everyone is married, don't you give up? Wang Xiaoli was so anxious that she couldn't help but say the name she didn't want to hear again. But the name has been in her ears for several years.

Shang Wenxiu said helplessly: "Mom, it's not what you think at all." After all these years, how could I possibly still have any thoughts about him? Although there are some things that you can't really let go of if you want to. But it's impossible for me to talk to him. It's just that I can't accept others in my heart all of a sudden. I'm a little tired, and I'll go back to my country in a while. ”

"You're coming back?" Wang Xiaoli asked in surprise.

"What? You don't want me to come back, do you? Shang Wenxiu pursed his mouth.

"How so? Your dad and I look forward to your return every day. However, the doctor-patient relationship in China is not very good now. You are much better off abroad than at home. Wang Xiaoli was a little happy and a little worried.

"It's fine. It's not like I haven't worked in China. After all, those medical troubles are also isolated phenomena. It's not for nothing abroad. There have been cases of doctors being shot and killed abroad. Shang Wenxiu said.

"Ah, then you better come back." Wang Xiaoli said in a hurry.

For the two women who had crossed paths in their lives in a hurry, Qin Chuan sometimes remembered them, but only to remember. Qin Chuan, who now has a family and has become a father-to-be, naturally will not have any distracting thoughts.

Qin Chuan's life was hurried and fulfilling, and in the R&D center, he wanted to be a provider of advanced technology. At home, he wants to be a good son, son-in-law, and husband, and a good father in the future.

Jiang Lingling doesn't have much ambition, and she has now put all her energy into the child in her belly. I used to be a nurse, but now I'm a doctor. Jiang Lingling is naturally very clear about what kind of state the child is in the belly. The more you know, the more you can't let go. I am afraid that the fetus will be compressed, and I am afraid that the fetus will not be in a good position. It is also necessary to maintain a good mood so that the fetus can feel happy in the womb.

Even during this time, Jiang Lingling ignored Qin Chuan a little. Of course, attentive mothers-to-be often wake up. The marriage said apologetically to Qin Chuan: "Chuan, I'm sorry. I'm so nervous about my son these days. Isn't there something that ignores you? ”

Qin Chuan's whole mind was also focused on the child, so he didn't notice it, and even if he did, he wouldn't mind: "What to say." The most important thing now is our son. ”

"Well, don't be too busy. I know that the heart in the R&D center has accelerated. You must be very tired. Jiang Lingling noticed that she didn't notice that her husband had lost weight at all.

"Tired, tired. I used to be too idle. Although I am a little busy for a while, when these teams are on the right track, I will be idle. When the time comes, I just want to do more. I'm afraid I won't have a chance. Qin Chuan smiled and stroked Jiang Lingling's slightly messy hair.

"Then don't tire yourself out." Jiang Lingling admonished.

With the addition of Sun Chaokun's intelligent technology team, the progress of the Kangmo team has accelerated a lot. After all, the team doesn't know a lot about intelligent statistical software. Now with the participation of professionals, the progress of research is naturally much faster.

After half a month of working together as a team, Qin Chuan got good news.

"Dr. Qin. Our two teams have paid off. We have successfully developed a Chinese medicine formula for the treatment of MERS virus. After being made into Chinese patent medicine, the effect is very ideal, and the ability to inhibit the virus is very strong. Kang Mo said.

Although monoclonal antibodies to the MERS virus are already available, the cost of monoclonal antibodies is expensive, and the price is naturally not low. And it has very limited effect against variants of the MERS virus. In terms of the scope of application. It is not even as good as the traditional Chinese medicine formula given by Qin Chuan in the early days.

Therefore, Qin Chuan pays more attention to the adaptability of this new drug. "How effective is it for MERS1?"

"Very good. We tried several MERS variant types, all of which had very good inhibitions. Much more effective than the previous free formula. With special effects. Kang Mo was very excited.

"In this case, notify the R&D department to conduct clinical trials. Get to market as quickly as possible. Your focus is still on the work of intelligent formulations of traditional Chinese medicine. It is necessary to take advantage of the cooperation between the two teams to solve the technical problems. I won't have such a good opportunity in the future. Qin Chuan said.

Qin Chuan is still very concerned about the progress of the Kang Mo team. After all, he still has a system task that he has not completed. Now, he finds himself getting more and more exposed to the heart of TCM. The main purpose of the system to issue such a task is naturally to carry forward traditional Chinese medicine. Illustrate. Even in the future, TCM will continue to play a very important role.

The biggest problem in Chinese medicine is that Chinese medicine is often one person and one disease. Unlike Western medicine, the same disease, technology has a programmed treatment process. There is almost a fixed set of prescriptions for prescriptions. In this way, it is very conducive to the transfer of technology. But Chinese medicine is different. TCM prescribes medicine according to the patient's specific situation. For the same disease, or even for the same patient, it is almost impossible for different Chinese medicine practitioners to prescribe the same medicine. Although TCM seems to be more tailored to local conditions and different from person to person. However, it has limited the development of traditional Chinese medicine.

The intelligent formulation system may be able to solve the problem of traditional Chinese medicine in this regard. It can take the patient's physical indicators into account in the formula, and comprehensively consider the combination of various drugs. Give the best recipe. Once this system is fully finalized, it may open up a whole new path for the development of Chinese medicine.

Soon, the news that H&Q Group had developed a MERS virus special effect Chinese patent medicine was reported in key domestic media. It makes the domestic Chinese medicine practitioners very excited. From the beginning of the spread of the MERS virus, H&Q Group released a free formula, and now it has developed a special Chinese patent medicine, which is a very big progress. Traditional Chinese medicine (TCM) has played an extremely important role in the fight against MERS.

Koreans introduced a batch of monoclonal antibodies from H&Q Group, but found that this monoclonal antibody is very effective against the general MERS virus, but for some mutant types, the effect is extremely limited. In addition, the virus continues to spread in South Korea, and the number of quarantined people is increasing. Had to buy a large number of vaccines from H&Q. But there is still no way to deal with patients who have been infected with the mutant. As the number of variants increases, the role of vaccines becomes extremely limited.

"Why are the Chinese developing a special drug, while our researchers are still helpless?" South Korea's female president is very dissatisfied with her country's medical experts.

South Koreans have long surpassed China in the share of the international TCM market. Most of China's share is dominated by the export of raw materials for Chinese herbal medicines. But now, the research progress of MERS special effect Chinese patent medicine is significantly lagging behind China, so that South Koreans have to spend high prices to import therapeutic drugs from China, so how can South Koreans, who have always been desperate for face, pull down?

"In recent years, Han Group has sprung up, not only in traditional Chinese medicine, but also in modern medicine. Miracle drugs for various diseases emerge one after another. Its share in the world pharmaceutical market is increasing year by year. Now even the American pharmaceutical giants have to deal with the impact of H&Q Group. I didn't expect them to turn to the Chinese medicine industry now, and as soon as they came up, they produced a special drug for the MERS virus. Korean TCM experts said with shame.

Face is face, and if you can't deal with the MERS virus, that's what you lose. Soon Han Group received orders from Koreans. Only then did I get the MERS virus special drug with the drug approval word through the special drug approval shortcut in China, and soon obtained the license in South Korea at lightning speed.

The special drug is worthy of being a special drug, and it is very effective in treating MERS patients. Several MERS patients were soon cured and discharged. It also made Han Academy's traditional Chinese medicine an instant hit in South Korea.

Koreans are not the only ones who are nervous, the Japanese have more market in the traditional Chinese medicine market outside of China. The Japanese hold the vast majority of patents for traditional Chinese medicine, and many of them even come from prescriptions in ancient Chinese texts. They occupy more of the international market for TCM than Koreans.

This time, H&Q Group is clearly ahead of the Japanese.

Tashiro, the president of Nishimura Co., Ltd., was very dissatisfied with this situation, and pointed at the nose of the head of the R&D department at the meeting and scolded: "This is our greatest shame." After you easily got the Chinese's formula, you still lagged behind the Chinese in research. You know, we have the world's most advanced TCM research technology. But we were utterly defeated. ”

Ando, head of the R&D department, said stiffly: "President, although we have more patents than Chinese, we are indeed in a backward position in the development of proprietary Chinese medicines. After all, the Chinese have resources beyond our reach. And now, with the gradual increase in the price of Chinese herbal medicines, some of our cooperative medicinal material bases are no longer willing to cooperate with us. What's even more worrying is that H&Q Group is buying up some of the secret recipes of traditional Chinese medicine families at a high price. I think this failure is related to the secret recipe of the Chinese. ”

"These are excuses! Ando, you should be ashamed of your dereliction of duty. It seems that H&Q Group is going to make a difference in the Chinese medicine market. We must pay attention. Of course, we can also create some trouble for Chinese in terms of TCM patents. Tashiro smiled treacherously. Nishimura Co., Ltd. has applied for a large number of patents in traditional Chinese medicine technology, which is like a landmine. As long as China's traditional Chinese medicine companies enter the international market, they may hit mines if they are not careful. (To be continued.) )

...